» Articles » PMID: 3779655

Induction of Prostate Carcinoma in Situ at High Incidence in F344 Rats by a Combination of 3,2'-dimethyl-4-aminobiphenyl and Ethinyl Estradiol

Overview
Journal Cancer Res
Specialty Oncology
Date 1986 Dec 1
PMID 3779655
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Male F344 rats were given a diet containing 0.75 ppm of ethinyl estradiol for 3 weeks and a basal diet for 2 weeks alternately 10 times, and 2 days after each change to basal diet (on the third day of feeding of the basal diet), a single s.c. injection of 50 mg/kg body weight of 3,2'-dimethyl-4-aminobiphenyl. Then they were given the basal diet until week 60 and sacrificed for histological examination. Prostatic carcinomas were found in 18 of 21 rats (85.7%) after this treatment but in only 1 of 19 rats (5.2%) maintained on normal diet throughout the experiment but given 3,2'-dimethyl-4-aminobiphenyl at the same times as the diet given to test rats. All the carcinomas were microscopic and developed in the ventral lobe of the prostate. This method may ultimately lead to a useful animal model of prostatic carcinoma.

Citing Articles

Establishment of a syngeneic orthotopic model of prostate cancer in immunocompetent rats.

Suzuki S, Naiki-Ito A, Kuno T, Punfa W, Long N, Kato H J Toxicol Pathol. 2015; 28(1):21-6.

PMID: 26023257 PMC: 4337495. DOI: 10.1293/tox.2014-0050.


Establishment of an invasive prostate cancer model in transgenic rats by intermittent testosterone administration.

Sato S, Suzuki S, Naiki-Ito A, Komiya M, Ne L, Kato H J Toxicol Pathol. 2014; 27(1):43-9.

PMID: 24791066 PMC: 4000072. DOI: 10.1293/tox.2013-0052.


Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model.

Cho Y, Takahashi S, Asamoto M, Suzuki S, Tang M, Shirai T Prostate Cancer Prostatic Dis. 2007; 10(4):378-83.

PMID: 17457304 DOI: 10.1038/sj.pcan.4500971.


High susceptibility of the ACI and spontaneously hypertensive rat (SHR) strains to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) prostate carcinogenesis.

Inaguma S, Takahashi S, Ohnishi H, Suzuki S, Cho Y, Shirai T Cancer Sci. 2003; 94(11):974-9.

PMID: 14611674 PMC: 11160245. DOI: 10.1111/j.1349-7006.2003.tb01387.x.


Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment.

Cho Y, Takahashi S, Asamoto M, Suzuki S, Inaguma S, Hokaiwado N Cancer Sci. 2003; 94(2):153-7.

PMID: 12708490 PMC: 11160202. DOI: 10.1111/j.1349-7006.2003.tb01412.x.